KMT2D Loss Drives Adeno-to-Squamous Transition and Sensitizes TKI-Resistant Lung Cancer to AURKA Inhibition

The authors identified loss of the histone methyltransferase KMT2D as a critical event that disrupts adenocarcinoma lineage fidelity and promotes squamous transition.